TransMedics Shares Fall Amid Lower 1Q Profit

Dow Jones05-06
 

By Christopher Kuo

 

TransMedics shares plummeted after the company posted first-quarter profit and revenue that missed Wall Street's forecast.

Shares of the medical technology company fell 21% in after-hours trading on Tuesday to $75.03. The company's shares closed at $94.93. The stock is down 22% year to date.

The company posted a profit of $7.3 million, or 20 cents a share, compared with $25.7 million, or 70 cents a share, a year earlier.

Adjusted earnings were 30 cents a share, missing estimates of 62 cents, according to analysts polled by FactSet.

Revenue rose to $173.9 million from $143.5 million a year earlier. Analysts expected revenue of $174.5 million.

 

Write to Christopher Kuo at chris.kuo@wsj.com

 

(END) Dow Jones Newswires

May 05, 2026 18:01 ET (22:01 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment